Genflow Biosciences PLC

NEW
LSE:GENF (UK)  
£ 0.011 -0.00030 (-2.54%) Mar 28
At Loss
P/B:
6.91
Market Cap:
£ 4.02M ($ 5.21M)
Enterprise V:
£ 2.88M ($ 3.73M)
Volume:
4.39M
Avg Vol (2M):
723.15K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
4.39M
At Loss

Business Description

Description
Genflow Biosciences PLC is a preclinical biotechnology company focused on developing innovative biological interventions aimed at tackling the effects of aging, potentially slowing or halting the aging process and reducing the incidence of age-related diseases and thereby increasing life span. The company is also focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with age.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt No Debt
Equity-to-Asset 0.64
Interest Coverage No Debt
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 9.2
9-Day RSI 10.42
14-Day RSI 14.09
3-1 Month Momentum % 10.14
6-1 Month Momentum % -11.63
12-1 Month Momentum % 28.81

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.73
Quick Ratio 2.73
Cash Ratio 2.31

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % -12.39

Profitability Rank

Name Current Vs Industry Vs History
ROE % -139.1
ROA % -105.95
ROIC % -1316.05
ROC (Joel Greenblatt) % -45930
ROCE % -139.1

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 6.91
EV-to-EBIT -1.88
EV-to-EBITDA -1.89
EV-to-FCF -4.59
Earnings Yield (Greenblatt) % -53.2
FCF Yield % -25.09

Financials (Next Earnings Date:2025-05-07 Est.)

LSE:GENF's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Genflow Biosciences PLC Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil £)
EPS (TTM) (£) -0.005
Beta 4.8
3-Year Sharpe Ratio -
3-Year Sortino Ratio 0.01
Volatility % 180.46
14-Day RSI 14.09
14-Day ATR (£) 0.00133
20-Day SMA (£) 0.015505
12-1 Month Momentum % 28.81
52-Week Range (£) 0.0105 - 0.03406
Shares Outstanding (Mil) 349.71

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Genflow Biosciences PLC Filings

Filing Date Document Date Form
No Filing Data

Genflow Biosciences PLC Stock Events

Financials Calendars
Event Date Price (£)
No Event Data

Genflow Biosciences PLC Frequently Asked Questions

What is Genflow Biosciences PLC(LSE:GENF)'s stock price today?
The current price of LSE:GENF is £0.01. The 52 week high of LSE:GENF is £0.03 and 52 week low is £0.01.
When is next earnings date of Genflow Biosciences PLC(LSE:GENF)?
The next earnings date of Genflow Biosciences PLC(LSE:GENF) is 2025-05-07 Est..
Does Genflow Biosciences PLC(LSE:GENF) pay dividends? If so, how much?
Genflow Biosciences PLC(LSE:GENF) does not pay dividend.

Press Release

Subject Date
No Press Release